A TUMOR-SPECIFIC PRODRUG ACTIVATION STRATEGY FOR BREAST AND PANCREATIC-CANCER

被引：0
|
作者：
HARRIS, JD
HURST, H
LEMOINE, N
SIKORA, K
机构：
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,ICRF,ONCOL UNIT,LONDON W12 0NN,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT CLIN ONCOL,LONDON W12 0NN,ENGLAND
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1994年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [21] The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters
    Varzaru, Vlad Bogdan
    Eftenoiu, Anca-Elena
    Vlad, Daliborca Cristina
    Vlad, Cristian Sebastian
    Moatar, Aurica Elisabeta
    Popescu, Roxana
    Cobec, Ionut Marcel
    LIFE-BASEL, 2024, 14 (04):
  • [22] TUMOR-MARKERS FOR THE DIAGNOSIS OF PANCREATIC-CANCER
    KLAPDOR, R
    FORTSCHRITTE DER MEDIZIN, 1986, 104 (46) : 948 - 951
  • [23] TUMOR-SPECIFIC MORPHOLOGICAL PROGNOSTIC CRITERIA IN INVASIVE BREAST-CANCER
    BUSS, J
    MINGUILLON, C
    SCHONBERG, W
    LICHTENEGGER, W
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 820 - 821
  • [24] Genetic prodrug activation therapy for pancreatic cancer
    Rigg, AS
    Lemoine, NR
    CELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPY, 1999, 880 : 319 - 325
  • [25] Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging
    Willemieke S. Tummers
    Sarah E. Miller
    Nutte T. Teraphongphom
    Adam Gomez
    Idan Steinberg
    David M. Huland
    Steve Hong
    Sri-Rajasekhar Kothapalli
    Alifia Hasan
    Robert Ertsey
    Bert A. Bonsing
    Alexander L. Vahrmeijer
    Rutger-Jan Swijnenburg
    Teri A. Longacre
    George A. Fisher
    Sanjiv S. Gambhir
    George A. Poultsides
    Eben L. Rosenthal
    Annals of Surgical Oncology, 2018, 25 : 1880 - 1888
  • [26] Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging
    Tummers, Willemieke S.
    Miller, Sarah E.
    Teraphongphom, Nutte T.
    Gomez, Adam
    Steinberg, Idan
    Huland, David M.
    Hong, Steve
    Kothapalli, Sri-Rajasekhar
    Hasan, Alifia
    Ertsey, Robert
    Bonsing, Bert A.
    Vahrmeijer, Alexander L.
    Swijnenburg, Rutger-Jan
    Longacre, Teri A.
    Fisher, George A.
    Gambhir, Sanjiv S.
    Poultsides, George A.
    Rosenthal, Eben L.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) : 1880 - 1888
  • [27] Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit
    Maak, Matthias
    Nitsche, Ulrich
    Keller, Larissa
    Wolf, Petra
    Sarr, Marianne
    Thiebaud, Marine
    Rosenberg, Robert
    Langer, Rupert
    Kleeff, Joerg
    Friess, Helmut
    Johannes, Ludger
    Janssen, Klaus-Peter
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (10) : 1918 - 1928
  • [28] A novel tumor-specific oncolytic biological therapy against invasive pancreatic cancer
    Koujima, Takeshi
    Tazawa, Hiroshi
    Hori, Naoto
    Tamura, Shuta
    Kuroda, Shinji
    Kishimoto, Hiroyuki
    Nishizaki, Masahiko
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2015, 75
  • [29] Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy
    Gan, Hui K.
    Burgess, Antony W.
    Clayton, Andrew H. A.
    Scott, Andrew M.
    CANCER RESEARCH, 2012, 72 (12) : 2924 - 2930
  • [30] Pancreatic juice biomarker for detection of early stage pancreatic cancer using tumor-specific exosomal microRNAs
    Sakaue, Takahiko
    Iwamoto, Hideki
    Koga, Hironori
    Imamura, Yasuko
    Nakamura, Toru
    Masuda, Atsutaka
    Tanaka, Toshimitsu
    Suzuki, Hiroyuki
    Ushijima, Tomoyuki
    Okabe, Yoshinobu
    Torimura, Takuji
    CANCER RESEARCH, 2020, 80 (16)
12345